Protective effects of nebivolol against cold restraint stress-induced gastric ulcer in rats: role of NO, HO-1, and COX-1,2.
Nebivolol, a β(1)-adrenoceptor antagonist, exhibits vasodilatory and anti-oxidative properties that rendering it attractive candidate for protecting against gastric ulcer. The aim of this study therefore is to evaluate the protective effects of nebivolol against cold restraint stress (CRS)-induced gastric ulcer in rats. Rats were restrained, and maintained at 4°C for 3 h. Nebivolol (5 mg/kg, p.o.) was suspended in 0.5% aqueous solution of carboxymethyl cellulose and was administered 30 min before CRS. Nebivolol exhibited gastroprotective effects as evidenced by significant decreases in ulcer index as well as free and total acid output, and pepsin activity in gastric juice in addition to gastric mucosal malondialdehyde concentration, with concomitant increases in gastric juice pH and mucin concentration along with gastric mucosal reduced glutathione and nitric oxide (NO) concentrations compared with CRS rats. Moreover, immunohistochemical analysis demonstrated that nebivolol treatment markedly enhanced heme oxygenase-1 as well as cyclooxygenase-1 and cyclooxygenase-2 expressions. The protective effects of nebivolol were confirmed by gastric histopathological examination. Pretreatment with N(ω)-nitro-L-arginine, a NO synthase inhibitor, partly altered the protection afforded by nebivolol. In conclusion, nebivolol protected rats' gastric mucosa against CRS-induced gastric ulceration possibly through anti-oxidant activity, enhancement of gastric mucosal barrier and reduction in acid secretory parameters.
Department of Pharmacology, Faculty of Medicine, El-Minia University, El-Minia, Egypt. mamm222@hotmail.com
Mohamed A
MA
Morsy
Gehan H
GH
Heeba
Soha A
SA
Abdelwahab
Remon R
RR
Rofaeil
D000818:Animals; D001578:Benzopyrans / Q000494:pharmacology*; D004983:Ethanolamines / Q000494:pharmacology*; D005750:Gastric Juice / Q000737:chemistry / Q000187:drug effects; D005753:Gastric Mucosa / Q000737:chemistry / Q000187:drug effects; D006651:Histocytochemistry; D008297:Male; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D000068577:Nebivolol; D009569:Nitric Oxide / Q000378:metabolism*; D020011:Protective Agents / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013276:Stomach Ulcer / Q000378:metabolism / Q000517:prevention & control*
D001578:Benzopyrans; D004983:Ethanolamines; D020011:Protective Agents; D000068577:Nebivolol; D009569:Nitric Oxide; D006899:Mixed Function Oxygenases